Showing results (651-660 of 977) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
NPJ Breast Cancer|February 7, 2026
Estrogen receptor β target gene expression reveals novel repressive functions in aggressive breast cancerSpyros Tastsoglou, Ilias V Karagounis, Marios Miliotis, et al.
NPJ Breast Cancer|December 13, 2025
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat studyMartina Rotolo, Claudia Piombino, Marta Venturelli, et al.
NPJ Breast Cancer|December 9, 2025
Biomarker prediction of immunotherapy response in breast cancer: from single markers to multi-omics integrationAli Sanjari Moghaddam, Kit Y Lu, Elham Nasrollahi, et al.
NPJ Breast Cancer|July 31, 2020
Olaparib for metastatic breast cancer in a patient with a germline PALB2 variantSherko Kuemmel, Hakima Harrach, Rita K Schmutzler, et al.
NPJ Breast Cancer|July 29, 2022
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapyRomy Aarnoutse, Janine Ziemons, Lars E Hillege, et al.
NPJ Breast Cancer|October 3, 2018
Androgen receptor expression in normal breast tissue and subsequent breast cancer riskKevin H Kensler, Francisco Beca, Gabrielle M Baker, et al.
NPJ Breast Cancer|April 8, 2022
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancerHaven R Garber, Akshara Singareeka Raghavendra, Michael Lehner, et al.
NPJ Breast Cancer|April 22, 2022
Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patientsLi Hu, Jie Sun, Zhongwu Li, et al.
NPJ Breast Cancer|July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
Pageof 98